Element Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Element Capital Management LLC

  • $10.1 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $5.25 Million - $7.27 Million
-17,531 Closed
0 $0
Q1 2019

May 13, 2019
SELL
$372.08 - $439.57 $5.62 Million - $6.64 Million
-15,111 Reduced 46.29%
17,531 $7.2 Million
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $12 Million - $14.5 Million
-35,875 Reduced 52.36%
32,642 $12.2 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $24.1 Million - $28 Million
68,517 New
68,517 $27.7 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email